Self-Administered Parenteral Trends and Forecast
The future of the global self-administered parenteral market looks promising with opportunities in the cardiovascular disease, diabetes, osteoporosis, pain management, and hormone replacement markets. The global self-administered parenteral market is expected to grow with a CAGR of 5.5% from 2024 to 2030. The major drivers for this market are growing significance of specialty drugs & biologics, increasing acceptance of options for home-based therapy, and growing use of smart injection tools.Self-Administered Parenteral by Segment
The study includes a forecast for the global self-administered parenteral by product type, usage, distribution channel, application, and region.Self-Administered Parenteral Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:
- Pre-Filled Syringes
- Auto injectors
- Pen Injectors
- Others
Self-Administered Parenteral Market by Usage [Shipment Analysis by Value from 2018 to 2030]:
- Disposable
- Reusable
Self-Administered Parenteral Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:
- Hospital Pharmacies
- Online Pharmacies
- Home Healthcare Providers
- Specialty Clinics
- Others
Self-Administered Parenteral Market by Application [Shipment Analysis by Value from 2018 to 2030]:
- Cardiovascular Diseases
- Diabetes
- Osteoporosis
- Pain Management
- Hormone Replacement
- Others
Self-Administered Parenteral Market by Region [Shipment Analysis by Value from 2018 to 2030]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
List of Self-Administered Parenteral Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies self-administered parenteral companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base.Some of the self-administered parenteral companies profiled in this report include:
- Becton, Dickinson and Company
- scPharmaceuticals
- Harro Höfliger
- Owen Mumford
- Haselmeier
- Stevanato Group
- Ypsomed AG
- Solteam Group
- AstraZeneca
- Enable Injections
Self-Administered Parenteral Market Insights
The publisher forecasts that pre-filled syringe is expected to witness the highest growth over the forecast period due to its growing demand for practical and safe medicine delivery systems.Within this market, pain management is expected to witness the highest growth over the forecast period.
APAC is expected to witness the highest growth over the forecast period.
Features of the Global Self-Administered Parenteral Market
- Market Size Estimates: Self-administered parenteral market size estimation in terms of value ($B).
- Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
- Segmentation Analysis: Self-administered parenteral market size by various segments, such as by product type, usage, distribution channel, application, and region in terms of value ($B).
- Regional Analysis: Self-administered parenteral market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different product types, usages, distribution channels, applications, and regions for the self-administered parenteral market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the self-administered parenteral market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the growth forecast for self-administered parenteral market?Answer: The global self-administered parenteral market is expected to grow with a CAGR of 5.5% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the self-administered parenteral market?
Answer: The major drivers for this market are growing significance of specialty drugs & biologics, increasing acceptance of options for home-based therapy, and growing use of smart injection tools.
Q3. What are the major segments for self-administered parenteral market?
Answer: The future of the self-administered parenteral market looks promising with opportunities in the cardiovascular disease, diabetes, osteoporosis, pain management, and hormone replacement markets.
Q4. Who are the key self-administered parenteral market companies?
Answer: Some of the key self-administered parenteral companies are as follows:
- Becton, Dickinson and Company
- scPharmaceuticals
- Harro Höfliger
- Owen Mumford
- Haselmeier
- Stevanato Group
- Ypsomed AG
- Solteam Group
- AstraZeneca
- Enable Injections
Answer: The publisher forecasts that pre-filled syringe is expected to witness the highest growth over the forecast period due to its growing demand for practical and safe medicine delivery systems.
Q6. In self-administered parenteral market, which region is expected to be the largest in next 5 years?
Answer: APAC is expected to witness the highest growth over the forecast period.
Q7. Do we receive customization in this report?
Answer: Yes, the publisher provides 10% customization without any additional cost.
This report answers the following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the self-administered parenteral market by product type (pre-filled syringes, auto injectors, pen injectors, and others), usage (disposable and reusable), distribution channel (hospital pharmacies, online pharmacies, home healthcare providers, specialty clinics, and others), application (cardiovascular diseases, diabetes, osteoporosis, pain management, hormone replacement, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Global Self-Administered Parenteral Market : Market Dynamics
3. Market Trends and Forecast Analysis from 2018 to 2030
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
5. Competitor Analysis
6. Growth Opportunities and Strategic Analysis
7. Company Profiles of Leading Players
Companies Mentioned
- Becton, Dickinson and Company
- scPharmaceuticals
- Harro Höfliger
- Owen Mumford
- Haselmeier
- Stevanato Group
- Ypsomed AG
Methodology
The analyst has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets/applications and served over 1,000 clients worldwide. Each study is a culmination of four months of full-time effort performed by the analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in the market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of professionals, who have analyzed and tracked the market over the years.
Extensive research and interviews are conducted in the supply chain of the market to estimate market share, market size, trends, drivers, challenges and forecasts.
Thus, the analyst compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. The analyst then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process.
LOADING...
![Pharmaceutical Packaging Market by Type (Bottle, Vial, Blister Pack, Ampoule, Pre-filled Syringe), Material (Plastic [PE, Polyvinyl chloride, PP, PET], Paper, Glass, Metal), Dosage Form (Oral, Parenteral, Topical), End User-Global Forecast to 2031 - Product Image](http://www.researchandmarkets.com/product_images/12634/12634630_60px_jpg/pharmaceutical_packaging_market.jpg)
